Pharmacological Effects and Toxicity Studies
Pharmacological Effects and Toxicity Studies is a research topic within Pediatrics, Perinatology and Child Health. Science Explorer counts 50k research works in it since 1950. 18.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the effects of prenatal exposure to antiepileptic drugs (AEDs) on neurodevelopment, teratogenicity, cognitive function, bone health, and oxidative stress. It also explores the impact of maternal epilepsy on fetal development and the association with neurodevelopmental disorders and malformations.
- Antiepileptic Drugs
- Prenatal Exposure
- Teratogenicity
- Neurodevelopmental Disorders
- Cognitive Function
- Malformations
- Bone Health
- Oxidative Stress
- Maternal Epilepsy
- Fetal Development
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 9.2k per year above
- Top-10% rate
- 18.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pharmacological Effects and Toxicity Studies research?
By volume, the United States and China publish the most (1.4k and 655 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 655 works
- 3 India 495 works
- 4 United Kingdom 280 works
- 5 Japan 256 works
- 6 Germany 241 works
- 7 Türkiye 222 works
- 8 Italy 181 works
- 9 France 174 works
- 10 Brazil 161 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pharmacological Effects and Toxicity Studies research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Pharmacological Effects and Toxicity Studies research, followed by University College London and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 All India Institute of Medical Sciences India 23 works
- 2 University College London United Kingdom 23 works
- 3 University of North Carolina at Chapel Hill United States 17 works
- 4 Sağlık Bilimleri Üniversitesi Türkiye 17 works
- 5 Sichuan University China 17 works
- 6 Philipps University of Marburg Germany 16 works
- 7 Harvard University United States 15 works
- 8 Charité - Universitätsmedizin Berlin Germany 15 works
- 9 Johns Hopkins University United States 15 works
- 10 Ain Shams University Egypt 15 works
Who are the leading researchers in Pharmacological Effects and Toxicity Studies?
The most-cited researchers publishing on Pharmacological Effects and Toxicity Studies include Giuseppe Remuzzi, Winfried März and Ettore Beghi.
- 1 Giuseppe Remuzzi 8.1k citations
- 2 Winfried März 5.2k citations
- 3 Ettore Beghi 4.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pharmacological Effects and Toxicity Studies research done?
The largest centres of Pharmacological Effects and Toxicity Studies research in 2022–2025 are London (United Kingdom), Beijing (China), Tokyo (Japan) and New York (United States).
Largest cities, 2022–2025
Where is the best place to study Pharmacological Effects and Toxicity Studies?
Among universities, judged by research, Karolinska Institutet, Monash University and University College London score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Karolinska Institutet Sweden | 54.1 | 40.0% | 3.6× | 10 | +4.9% |
| 2 | Monash University Australia | 51.6 | 34.3% | 2.2× | 11 | +115.9% |
| 3 | University College London United Kingdom | 49.0 | 21.5% | 2.7× | 23 | -5.5% |
| 4 | Philipps University of Marburg Germany | 48.1 | 11.2% | 10.9× | 16 | -20.6% |
| 5 | All India Institute of Medical Sciences India | 44.3 | 9.0% | 6.2× | 23 | +40.7% |
| 6 | Sichuan University China | 42.9 | 30.5% | 1.6× | 16 | +30.9% |
| 7 | University of Washington United States | 42.7 | 29.1% | 2.3× | 14 | +16.4% |
| 8 | Zagazig University Egypt | 42.2 | 4.5% | 5.6× | 13 | +232.1% |
| 9 | University of Pittsburgh United States | 41.5 | 32.9% | 2.7× | 13 | -17.1% |
| 10 | King Saud University Saudi Arabia | 40.3 | 27.9% | 1.5× | 9 | +75.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pharmacological Effects and Toxicity Studies research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Pharmacological Effects and Toxicity Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.